HLS Therapeutics (HLS.TO) Q3 2025 Earnings

14AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.21
-0.17
-0.14
-0.1

Details

Expected EPS
-0.10322869289999999
Actual EPS
-0.124317
Surprise EPS
-0.02
Surprise Percent
+20.43%

Description

HLS Therapeutics (HLS.TO) has reported earnings of -0.124317 per share for Q3 2025.

0 Comments

Share your thoughts